20
Participants
Start Date
May 31, 2008
Primary Completion Date
November 30, 2012
Study Completion Date
November 30, 2012
Darbepoetin alfa
Subjects will undergo anemia management with darbepoetin after baseline assessment of MGU and will continue for six months with repeat assessment of MGU at completion of protocol
Baltimore VA Medical Center, Baltimore
Collaborators (1)
Amgen
INDUSTRY
University of Maryland, Baltimore
OTHER